7 8 dihydroxyflavone powder also called 7,8-DHF. It is a compound flavonoid that was firstly discovered a study for small molecules that could activate a particular receptor known as tropomyosin-related kinase B (TrkB), because the peptide produced in the human body that acts on this receptor, called brain derived nootropics factor , could not be used due to poor absorption into the brain. 7,8-DHF is both orally-bioavailable and able to penetrate the blood-brain-barrier,though with a relatively short half-life.

Normal Specification

Main Function

The product has demonstrated remarkable therapeutic efficacy in animal models of a variety of central nervous system disorders, including depression, Alzheimer's disease, cognitive deficits in schizophrenia, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, traumatic brain injury, cerebral ischemia, fragile X syndrome, and Rett syndrome.

The product also shows efficacy in animal models of age-associated cognitive impairment and enhances memory consolidation and emotional learning in healthy rodents.

In addition, 7 8 dihydroxyflavone powder possesses powerful antioxidant activity independent of its actions on the TrkB receptor, and protects against glutamate-induced excitotoxicity, 6-hydroxydopamine-induced dopaminergic neurotoxicity, and oxidative stress-induced genotoxicity.